Business Services

Pharmaceutical Business Services – News, analysis and company profiles

Showing 15 posts of 2453 posts found.

AI drug discovery collaboration for rare disease cystinosis

March 10, 2022 Business Services

Insilico Medicine has entered a research and development collaboration with the Mechanisms of Inherited Kidney Disorders (MIKADO) group at the …

$31 million to progress pipeline of genetic modifiers in cancer and rare diseases

March 10, 2022 Business Services

Scenic Biotech has announced a Series A financing of roughly $31 million, supporting the creation of new programmes based on …

MHRA approves Phase I/II clinical trial of IN3BIO vaccine for colorectal cancer patients

March 10, 2022 Business Services

The MHRA has approved a Phase I/II clinical trial of IN3BIO’s colorectal cancer vaccine. This is the company’s second global …

Risk of hospitalisation five times higher with J&J

March 3, 2022 Business Services, Medical Communications

A study published in Jama Network Open has revealed that Johnson & Johnson’s coronavirus vaccine was far less effective at …

FDA grants breakthrough therapy designation to RSV vaccine

March 3, 2022 Business Services, Medical Communications

The FDA has granted a Breakthrough Therapy Designation to Pfizer’s respiratory syncytial virus (RSV) vaccine candidate, for the prevention of …

WHO recommends Merck’s COVID-19 pill

March 3, 2022 Business Services, Medical Communications

WHO have recommended Merck’s pill, molnupiravir, for the treatment of COVID-19 in patients in high risk groups, such as the …

South Korea approves Pfizer vaccine for children aged 5-11

February 24, 2022 Business Services

South Korea’s drug safety agency on authorised the use of Pfizer’s COVID-19 vaccine on 23 February, for children aged between …

CDC: some should wait longer for second COVID-19 vaccination

February 24, 2022 Business Services

The CDC updated its vaccine guidance for COVID-19, recommending that some American over the age of 12 who have received …

New sickle cell treatment administered to first patients in England

February 24, 2022 Business Services

Sickle cell patients have now begun receiving the first new treatment for the blood disorder in over 20 years. The …

NICE recommends GSK’s ZEJULA (niraparib) for ovarian cancer patients

February 24, 2022 Business Services

NICE has issued a Final Appraisal Determination (FAD), recommending the use of ZEJULA (niraparib) on the NHS. Niraparib is recommended …

FDA accepts NDA for non-small cell lung cancer treatment

February 17, 2022 Business Services

Mirati Therapeutics, a clinical-stage targeted oncology company has announced that the FDA has accepted the new drug application (NDA) for …

England to offer COVID-19 vaccine to five to 11-year-olds

February 17, 2022 Business Services

Children aged between five and 11 in England will be offered a low-dose vaccine, according to the government. This move …

First Promising Innovative Medicine designation for self-administered treatment of rare disease

February 17, 2022 Business Services

UCB has announced that zilucoplan, its developmental treatment for adults with generalized myasthenia gravis (gMG) has been granted Promising Innovative …

Virtual drug design platform to accelerate drug discovery

February 17, 2022 Business Services

The Cambridge Crystallographic Data Centre (CCDC) announced a strategic partnership with Dassault Systemes to advance bioscience innovation with a cloud-based …

First biologic medicine approved in China for lupus

February 10, 2022 Business Services

Nearly half a million people in China have systematic lupus erythematosus (SLE), and more than have of this number will …
The Gateway to Local Adoption Series

Latest content